Commercial Pharmaceutical Analytics Market Research Report - Global Forecast till 2027

Commercial Pharmaceutical Analytics Market Research Report: Information by Type (Descriptive Analytics, Predictive Analytics and Prescriptive Analytics), Application (R&D, Marketing & Sales, Supply Chain Optimization and Internal Reporting), Deployment (On-Premise and Web-Based/Cloud-Based), Components (Software and Services) - Global Forecast till 2027

ID: MRFR/HCIT/0332-CR | August 2019 | Region: Global | 137 pages

Please note that the assessment period of report has been updated from 2017-2027 to 2020-2027. Cordially fill the sample form for updated data.

Market Overview

The mining of massive amounts of scattered data along with the processing of data for aligning into useful information with the use of various commercial pharmaceutical analytical tools. These tools are used in various processes. To costs organization efficient workflow in the organisation for easing the workload of the organizations, commercial pharmaceutical analytics tools are used. These can be implemented in various software services for multiple services like client-based model/ web-based model and on premise-based model. Owing to change in the pharmaceutical industry due to commercial pharmaceutical analytics helps in life-science industries for the sophistication of resulting business and process by creating a positive impact. Owing to the increasing adoption rate, third-party commercial pharmaceutical analytics is also growing at a fast rate.

The commercial pharmaceutical analytics market is expected to show a high CAGR of 20% to account for a market value of USD 9,308 million by the end of the forecasted period from 2017 to 2027.

COVID 19 Analysis

Owing to the global pandemic of the COVID 19 situation, the businesses have affected abruptly. Owing to the outbreak of COVID 19 there were serious issues of hospital infrastructure and owing to the increasing demand for bedding it affected the healthcare facilities and because of this many manufacturing and IT, units were shut down due to which commercial pharmaceutical analytics industry showed a downfall in the market share.

But after the lockdown situation there was increasing demand for the commercial pharmaceutical analytics market and hence expected to recover at the end of the first quarter of the coming year during the forecasted period from 2016 to 2027.

Global Commercial Pharmaceutical Analytics Market Size, by Application, 2016 (USD Million)  Commercial Pharmaceutical Analytics Market


Source: MRFR Analysis


Market Dynamics


Drivers


Owing to the increasing use of technology all across the globe and now almost 80% of the population has internet access and it is used to search information regarding symptoms of diseases and their treatment and the effects and side effects of the drugs acting on it. Owing to this, commercial pharmaceutical analytics tools are in great use and hence drives commercial pharmaceutical analytics in the global market. It will help in providing customers with product information and pricing of their applications. This way of advertising is very commonly used and hence drives the commercial pharmaceutical analytics market.


Opportunities


Growing demand and use of smartphones and using this technology for advertisement are possible because of the commercial pharmaceutical analytics industry for reaching a specific consumer pool that will help in enhancing the business and helps in generating various growth opportunities for the growth of the commercial pharmaceutical analytics market in the global market. Also, it will reduce the burden on hospital staff and doctors.


Restraints


The commercial pharmaceutical analytics market has gained a lot of familiarity in the recent past and is growing tremendously but some factors restrain the growth of the commercial pharmaceutical analytics industry in the global market like the conservative nature of the healthcare industry and the lack of skilled professionals hampers the growth of commercial pharmaceutical analytics in the global market. Also, the framework is very complex as analytical tools go out of control.


Value Chain Analysis


The commercial pharmaceutical analytics market is growing at a fast speed owing to a growing need for optimizing research and development cost and hence increases the process efficiency in the working of the organisation. In the case of an emergency, if there is a lack of transportation it helps in providing the treatment for the time being before reaching the hospital. It also helps in reducing the overall workload in all the organisation that is using the commercial pharmaceutical analytics industry.


Asia-Pacific Commercial Pharmaceutical Analytics Market Share, by Country, 2016 (%)  Commercial Pharmaceutical Analytics Market


Source: MRFR Analysis


Market Segmentation


The commercial pharmaceutical analytics market in the global market is divided based on type, application, deployment, and components.


Based on the Type


The commercial pharmaceutical analytics market in the global market is divided based on type into perspective analytics, predictive analytics, and descriptive analytics.


Based on the Application


The commercial pharmaceutical analytics in the global market is divided based on application into internal reporting, supply chain optimization, marketing and sales, and research and development. Under this marketing and sales dividend accounts for the largest market share by USD 231.4 million by 2016.


Based on the Deployment


The commercial pharmaceutical analytics in the global market is divided based on deployment into web-based or cloud-based deployment and on premise-based deployment type.


Based on the Components


The commercial pharmaceutical analytics market in the global market is divided based on components into software and services.


Regional Analysis


The commercial pharmaceutical analytics in the global market is divided based on region into the America region, the Europe region, the Asia-Pacific region, and the Middle East and Africa region. The largest share in the commercial pharmaceutical analytics in the global market is held by the American region as this region has developed various commercial pharmaceutical analytics solutions and its application. The second-largest share is held by the European region owing to the increasing demand for commercial pharmaceutical analytics for various quantitative and subjective analyses.


In the global market, the Asia-Pacific region is the fastest-growing region owing to high growth opportunities in the various untapped market in the commercial pharmaceutical analytics industry. Many countries like China, India, Japan, and South Korea have high growth opportunities during the forecasted period. Owing to the slow growth rate, the commercial pharmaceutical analytics industry holds the least share in the global market.


Competitive Landscape


The most prominent major key players in the commercial pharmaceutical analytics market in the following market are as follows:



  • TRINITY PHARMA SOLUTIONS

  • TAKE Solutions Ltd.

  • Statistical Analysis System

  • SCIO HEALTH ANALYTICS

  • Northwest Analytics, Inc.

  • International Business Machines Corporation

  • CitiusTech Inc.

  • Wipro

  • ORACLE

  • IBM

  • Tata Consultancy Services Limited


These key players in the commercial pharmaceutical analytics market use various strategies like acquisition, product development, innovation, and expansion to increase the potential customer base in the global market that will increase the market share of these countries.


Recent Developments



  • In March 2017, Brilliant Service Co. Ltd. (Japan) has been acquired by Cognizant (U.S.), because of the increase in the adoption of the internet of things (IoT) for expanding the capabilities for digital strategy, engineering, and product design for enterprise mobility.

  • In July 2017, LabAnswer (U.S.) has been acquired by Accenture (Ireland) for strengthening the product portfolio of Accenture’s in digital technologies.

  • In February 2019, Linguamatics has been acquired by IQVIA for helping organizations portfolio of machine learning technologies and Artificial Intelligence (AI).

  • In May 2019, SAS Cloud offering has been developed by SAS Institute (U.S.) in Singapore in an Amazon Web Services Data Center.

  • In February 2020, Avacare Clinical Research Network had been launched by IQVIA for providing various opportunities and patient options in a global-based site network for clinical trials.


Report Overview


This global commercial pharmaceutical analytics market research report consists of the following aspects:



  • Market Overview

  • COVID 19 Analysis

  • Market Dynamics

  • Value Chain Analysis

  • Market Segmentation

  • Regional Analysis

  • Competitive Landscape

  • Recent Developments


This global commercial pharmaceutical analytics market research report contains various driving factors as well as various restraining factors that affect the commercial pharmaceutical analytics market in the global market. This report also contains the impact of the global pandemic on the market share. This future market share of the commercial pharmaceutical analytics market is also estimated and mentioned.


Users


Pharmaceutical companies, regulatory agencies, hospitals and clinics, government research organizations, medical device manufacturers and distributors, and many others.



Report Scope:
Report Attribute/Metric Details
  Market Size   9,308 Million
  CAGR   20%
  Base Year   2017
  Forecast Period   2027
  Historical Data   2016
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Application, Deployment and Components
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   TRINITY PHARMA SOLUTIONS, TAKE Solutions Ltd., Statistical Analysis System, SCIO HEALTH ANALYTICS, Northwest Analytics, Inc., International Business Machines Corporation, CitiusTech Inc., Wipro, ORACLE, IBM, Tata Consultancy Services Limited
  Key Market Opportunities   Smartphones and technology for advertisement in specific consumer pool
  Key Market Drivers

  • Increasing use of technology all across
  • Commercial pharmaceutical analytics tools



    • Frequently Asked Questions (FAQ) :

    Commercial pharmaceutical analytics market projected to grow at approximately 20.0% CAGR during the assessment period (2020-2027).

    The valuation of the global commercial pharmaceutical analytics market is estimated to increase to USD 9,308 million by the end of 2027.

    Spurting rise in the pharmaceutical and life science industry and the adoption of analytics in these industries are major tailwinds pushing the growth of the global commercial pharmaceutical analytics market.

    North America holds the largest share in the global commercial pharmaceutical analytics market, followed by Europe and the Asia Pacific, respectively.

    International Business Machines Corporation, Wipro Limited CitiusTech Inc., Northwest analytics, Inc., Scio Health Analytics, Trinity Pharma Solutions, ORACLE, Statistical Analysis System, Tata Consultancy Services Limited, and TAKE Solutions Ltd., are some of the top players operating in the global commercial pharmaceutical analytics market.

    1 Report Prologue

    2 Introduction

    2.1 Definition 17

    2.2 Scope of Study 18

    2.2.1 Research Objective 18

    2.2.2 Assumptions & Limitations 18

    2.2.2.1 Assumptions 18

    2.2.2.2 Limitations 18

    2.3 Market Structure: 19

    3 Research Methodology

    3.1 Introduction 20

    3.2 Primary Research 21

    3.3 Secondary research 21

    3.4 Market Size Estimation 22

    4 Market Dynamics

    4.1 Drivers 24

    4.1.1 Growing Adoption of New Technologies and Analytical Tools 24

    4.1.2 Regulation of R&D Productivity 24

    4.1.3 Growing Trend of the Big Data Advertisement in Pharma Sector. 25

    4.1.4 Increasing Usage of Analytical Tools in Streamlining Business Process 25

    4.2 Restraint 26

    4.2.1 Lack of Skilled Professionals 26

    4.2.2 Conservative Nature of Healthcare Industry. 26

    5 Market Factor Analysis

    5.1 Porter’s Five Forces Model 27

    5.1.1 Introduction 27

    5.1.2 Bargaining Power of Suppliers 28

    5.1.3 Bargaining Power of BUYERS: 28

    5.1.4 Intensity of Competitor’s: 28

    5.1.5 Threat of New Entrants 29

    5.1.6 Threat from Substitutes 29

    5.2 Value Chain Analysis 30

    5.2.1 Inputs 31

    5.2.2 Developments Process 31

    5.2.3 Output 31

    5.2.4 Marketing and Distribution 31

    5.2.5 Post Selling Services 31

    6 Global Commercial Pharmaceutical Analytics Market, by Type

    6.1 Introduction 32

    6.1.1 Descriptive Analytics 34

    6.1.2 Predictive Analytics 34

    6.1.3 Prescriptive Analytics 35

    7 Global Commercial Pharmaceutical Analytics Market, by Application

    7.1 Introduction 37

    7.2 R&D 39

    7.2.1 Marketing & Sales 40

    7.2.2 Supply Chain Optimization 40

    7.2.3 Internal Reporting 41

    8 Global Commercial Pharmaceutical Analytics Market, by Deployment

    8.1 On-Premise 45

    8.2 Web Based/Cloud Based 46

    9 Global Commercial Pharmaceutical Analytics Market, by Components

    9.1 Introduction 47

    9.2 Software 49

    9.3 Services 50

    10 Global Commercial Pharmaceutical Analytics Market, by Region

    10.1 Introduction 51

    10.2 Americas 53

    10.2.1 North America 57

    10.2.1.1 US 59

    10.2.1.2 Canada 61

    10.2.2 Latin America 63

    10.3 Europe 65

    10.3.1 Western Europe 69

    10.3.1.1 Germany 69

    10.3.1.2 France 71

    10.3.1.3 UK 73

    10.3.1.4 Italy 75

    10.3.1.5 Spain 77

    10.3.1.6 Rest of Western Europe 79

    10.3.2 Eastern Europe 81

    10.3.3 Asia-Pacific 83

    10.3.3.1 Japan 87

    10.3.3.2 China 89

    10.3.3.3 India 91

    10.3.3.4 South Korea 93

    10.3.3.5 Rest of Asia-Pacific 95

    10.3.4 Middle East & Africa 97

    11 Company Landscape

    11.1 Introduction 101

    11.1.1 Mergers Acquisitions 102

    11.1.2 Collaborations 103

    11.1.3 Release/New Product Launches 103

    11.1.4 Other (Expansion, Updates, Partnership) 104

    12 Company Profile

    12.1 CitiusTech Inc. 106

    12.1.1 Company Overview 106

    12.1.2 Product/Business Segment Overview 106

    12.1.3 Financial Overview 106

    12.1.4 Key Developments 106

    12.2 International Business Machines Corporation 107

    12.2.1 Company Overview 107

    12.2.2 Product/Business Segment Overview 107

    12.2.3 Financial Overview 108

    12.2.4 Key Developments 109

    12.3 Northwest analytics, Inc. 110

    12.3.1 Company Overview 110

    12.3.2 Product/Business Segment Overview 110

    12.3.3 Financial Overview 110

    12.3.4 Key Developments 110

    12.4 ORACLE 111

    12.4.1 Company Overview 111

    12.4.2 Product/Business Segment Overview 111

    12.4.3 Financial Overview 112

    12.4.4 Key Developments 113

    12.5 SCIO HEALTH ANALYTICS 114

    12.5.1 Company Overview 114

    12.5.2 Product/Business Segment Overview 114

    12.5.3 Financial Overview 114

    12.5.4 Key Developmentss 115

    12.6 Statistical Analysis System 116

    12.6.1 Company Overview 116

    12.6.2 Product/Business Segment Overview 116

    12.6.3 Financial Overview 117

    12.6.4 Key Developments 118

    12.7 TAKE Solutions Ltd 119

    12.7.1 Company Overview 119

    12.7.2 Product/Business Segment Overview 119

    12.7.3 Financial Overview 120

    12.7.4 Key Developmentss 121

    12.8 Tata Consultancy Services Limited 122

    12.8.1 Company Overview 122

    12.8.2 Product/Business Segment Overview 122

    12.8.3 Financial Overview 123

    12.8.4 Key Developments 124

    12.9 TRINITY PHARMA SOLUTIONS 125

    12.9.1 Company Overview 125

    12.9.2 Product/Business Segment Overview 125

    12.9.3 Financial Overview 125

    12.9.4 Key Developmentss 125

    12.10 Wipro Limited 126

    12.10.1 Company Overview 126

    12.10.2 Product/Business Segment Overview 126

    12.10.3 Financial Overview 127

    12.10.4 Key Developments 128

    13 Conclusion

    13.1 Key Findings 129

    14 Appendix

    15 List of Tables

    TABLE 1 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2020–2027 32

    TABLE 2 GLOBAL DESCRIPTIVE ANALYTICS MARKET, BY REGION (USD MILLION) 2020–2027 34

    TABLE 3 GLOBAL PREDICTIVE ANALYTICS MARKET, BY REGION (USD MILLION) 2020–2027 35

    TABLE 4 GLOBAL PRESCRIPTIVE ANALYTICS MARKET, BY REGION (USD MILLION) 2020–2027 36

    TABLE 5 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS, BY APPLICATION (USD MILLION) 2020–2027 37

    TABLE 6 GLOBAL RESEARCH & DEVELOPMENTS IN COMMERCIAL PHARMACEUTICAL ANALYTICS, BY REGION (USD MILLION) 2020–2027 39

    TABLE 7 GLOBAL MARKETING & SALES IN COMMERCIAL PHARMACEUTICAL ANALYTICS, BY REGION (USD MILLION) 2020–2027 40

    TABLE 8 GLOBAL SUPPLY CHAIN IN COMMERCIAL PHARMACEUTICAL ANALYTICS, BY REGION (USD MILLION) 2020–2027 41

    TABLE 9 GLOBAL INTERNAL REPORTING IN COMMERCIAL PHARMACEUTICAL ANALYTICS, BY REGION (USD MILLION) 2020–2027 42

    TABLE 10 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2020–2027 43

    TABLE 11 ON PREMISE MODEL IN COMMERCIAL PHARMACEUTICAL ANALYTICS, BY REGION (USD MILLION) 2020–2027 45

    TABLE 12 WEB BASED/CLOUD BASED MODEL IN COMMERCIAL PHARMACEUTICAL ANALYTICS, BY REGION (USD MILLION) 2020–2027 46

    TABLE 13 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS, BY COMPONENTS (USD MILLION) 2020–2027 47

    TABLE 14 GLOBAL SOFTWARE COMPONENTS IN COMMERCIAL PHARMACEUTICAL ANALYTICS, BY REGION (USD MILLION) 2020–2027 49

    TABLE 15 GLOBAL SERVICES COMPONENTS IN COMMERCIAL PHARMACEUTICAL ANALYTICS, BY REGION (USD MILLION) 2020–2027 50

    TABLE 16 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION (USD MILLION) 2020–2027 51

    TABLE 17 AMERICAS COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION (USD MILLION) 2020–2027 54

    TABLE 18 AMERICAS COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2020–2027 55

    TABLE 19 AMERICAS COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATONS (USD MILLION) 2020–2027 55

    TABLE 20 AMERICAS COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2020–2027 56

    TABLE 21 AMERICAS COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS (USD MILLION) 2020–2027 56

    TABLE 22 NORTH AMERICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2020–2027 57

    TABLE 23 NORTH AMERICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION (USD MILLION) 2020–2027 57

    TABLE 24 NORTH AMERICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2020–2027 58

    TABLE 25 NORTH AMERICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENT (USD MILLION) 2020–2027 58

    TABLE 26 US COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2020–2027 59

    TABLE 27 US COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION (USD MILLION) 2020–2027 59

    TABLE 28 US COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2020–2027 60

    TABLE 29 US COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS (USD MILLION) 2020–2027 60

    TABLE 30 CANADA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2020–2027 61

    TABLE 31 CANADA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION (USD MILLION) 2020–2027 61

    TABLE 32 CANADA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2020–2027 62

    TABLE 33 CANADA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS (USD MILLION) 2020–2027 62

    TABLE 34 LATIN AMERICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2020–2027 63

    TABLE 35 LATIN AMERICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION (USD MILLION) 2020–2027 63

    TABLE 36 ATIN AMERICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2020–2027 64

    TABLE 37 LATIN AMERICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS (USD MILLION) 2020–2027 64

    TABLE 38 EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION (USD MILLION) 2020–2027 66

    TABLE 39 EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2020–2027 67

    TABLE 40 EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION (USD MILLION) 2020–2027 67

    TABLE 41 EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2020–2027 68

    TABLE 42 EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS (USD MILLION) 2020–2027 68

    TABLE 43 GERMANY COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2020–2027 69

    TABLE 44 GERMANY COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION (USD MILLION) 2020–2027 69

    TABLE 45 GERMANY COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2020–2027 70

    TABLE 46 GERMANY COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS (USD MILLION) 2020–2027 70

    TABLE 47 FRANCE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2020–2027 71

    TABLE 48 FRANCE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION (USD MILLION) 2020–2027 71

    TABLE 49 FRANCE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2020–2027 72

    TABLE 50 FRANCE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS (USD MILLION) 2020–2027 72

    TABLE 51 UK COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2020–2027 73

    TABLE 52 UK COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION (USD MILLION) 2020–2027 73

    TABLE 53 UK COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2020–2027 74

    TABLE 54 UK COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS (USD MILLION) 2020–2027 74

    TABLE 55 ITALY COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2020–2027 75

    TABLE 56 ITALY COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION (USD MILLION) 2020–2027 75

    TABLE 57 ITALY COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2020–2027 76

    TABLE 58 ITALY COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS (USD MILLION) 2020–2027 76

    TABLE 59 SPAIN COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2020–2027 77

    TABLE 60 SPAIN COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION (USD MILLION) 2020–2027 77

    TABLE 61 SPAIN COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2020–2027 78

    TABLE 62 SPAIN COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS (USD MILLION) 2020–2027 78

    TABLE 63 REST OF WESTERN EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2020–2027 79

    TABLE 64 REST OF WESTERN EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION (USD MILLION) 2020–2027 79

    TABLE 65 REST OF WESTERN EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2020–2027 80

    TABLE 66 REST OF WESTERN EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS (USD MILLION) 2020–2027 80

    TABLE 67 EASTERN EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2020–2027 81

    TABLE 68 EASTERN EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION (USD MILLION) 2020–2027 81

    TABLE 69 EASTERN EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2020–2027 82

    TABLE 70 EASTERN EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS (USD MILLION) 2020–2027 82

    TABLE 71 ASIA-PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION (USD MILLION) 2020–2027 84

    TABLE 72 ASIA-PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2020–2027 85

    TABLE 73 ASIA-PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION (USD MILLION) 2020–2027 85

    TABLE 74 ASIA-PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2020–2027 86

    TABLE 75 ASIA-PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENT (USD MILLION) 2020–2027 86

    TABLE 76 JAPAN COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2020–2027 87

    TABLE 77 JAPAN COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION (USD MILLION) 2020–2027 87

    TABLE 78 JAPAN COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2020–2027 88

    TABLE 79 JAPAN COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENT (USD MILLION) 2020–2027 88

    TABLE 80 CHINA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2020–2027 89

    TABLE 81 CHINA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION (USD MILLION) 2020–2027 89

    TABLE 82 CHINA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2020–2027 90

    TABLE 83 CHINA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENT (USD MILLION) 2020–2027 90

    TABLE 84 INDIA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2020–2027 91

    TABLE 85 INDIA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION (USD MILLION) 2020–2027 91

    TABLE 86 INDIA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2020–2027 92

    TABLE 87 INDIA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENT (USD MILLION) 2020–2027 92

    TABLE 88 SOUTH KOREA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2020–2027 93

    TABLE 89 SOUTH KOREA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION (USD MILLION) 2020–2027 93

    TABLE 90 SOUTH KOREA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2020–2027 94

    TABLE 91 SOUTH KOREA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENT (USD MILLION) 2020–2027 94

    TABLE 92 REST OF ASIA PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2020–2027 95

    TABLE 93 REST OF ASIA PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION (USD MILLION) 2020–2027 95

    TABLE 94 REST OF ASIA PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2020–2027 96

    TABLE 95 REST OF ASIA PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENT (USD MILLION) 2020–2027 96

    TABLE 96 MIDDLE EAST & AFRICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION (USD MILLION) 2020–2027 97

    TABLE 97 MIDDLE EAST & AFRICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2020–2027 98

    TABLE 98 MIDDLE EAST & AFRICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION (USD MILLION) 2020–2027 99

    TABLE 99 MIDDLE EAST & AFRICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2020–2027 99

    TABLE 100 MIDDLE EAST & AFRICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS (USD MILLION) 2020–2027 100

    16 List of Figures

    FIGURE 2 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET SHARE, BY TYPE, 2020 (%) 14

    FIGURE 3 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET SHARE, BY APPLICATION, 2020 (%) 14

    FIGURE 4 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET SHARE, BY DEPLOYMENT, 2020 (%) 15

    FIGURE 5 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET SHARE, BY COMPONENT, 2020 (%) 15

    FIGURE 6 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET SHARE, BY REGION, 2020 (%) 16

    FIGURE 7 RESEARCH PROCESS 20

    FIGURE 8 FORECAST MODEL 23

    FIGURE 9 VALUE CHAIN ANALYSIS 30

    FIGURE 10 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2020 & 2027 33

    FIGURE 11 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS, BY APPLICATION (USD MILLION) 2020 & 2027 38

    FIGURE 12 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2020 & 2027 44

    FIGURE 13 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS, BY COMPONENTS (USD MILLION) 2020 & 2027 48

    FIGURE 14 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION (USD MILLION) 2020–2027 52

    FIGURE 15 AMERICAS COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION MARKET SHARE 2020 (%) 54

    FIGURE 16 EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION MARKET SHARE 2020 (%) 66

    FIGURE 17 ASIA-PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION MARKET SHARE 2020 (%) 84

    FIGURE 18 MIDDLE EAST & AFRICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION (USD MILLION) 2020–2027 98

    FIGURE 19 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET SHARE ANALYSIS 2020 (%) 101

    FIGURE 20 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET COMPETITIVE ANALYSIS 2020 (%) 102

    FIGURE 21 RECENT FINANCIALS 108

    FIGURE 22 GEOGRAPHIC REVENUE MIX, 2020 (%) 108

    FIGURE 23 SEGMENTAL REVENUE MIX, 2020 (%) 109

    FIGURE 24 RECENT FINANCIALS 112

    FIGURE 25 GEOGRAPHIC REVENUE MIX, 2020 (%) 112

    FIGURE 26 SEGMENTAL REVENUE MIX, 2020 (%) 113

    FIGURE 27 RECENT FINANCIALS 117

    FIGURE 28 GEOGRAPHIC REVENUE MIX, 2020 117

    FIGURE 29 SEGMENTAL REVENUE MIX, 2020 118

    FIGURE 30 RECENT FINANCIALS (USD MILLION) 120

    FIGURE 31 GEOGRAPHIC REVENUE MIX, 2020 (%) 120

    FIGURE 32 SEGMENTAL REVENUE MIX, 2020 (%) 121

    FIGURE 33 RECENT FINANCIALS 123

    FIGURE 34 GEOGRAPHIC REVENUE MIX, 2020 (%) 123

    FIGURE 35 SEGMENTAL MIX, 2020 (%) 124

    FIGURE 36 RECENT FINANCIALS 127

    FIGURE 37 GEOGRAPHIC REVENUE MIX, 2020 (%) 127

    FIGURE 38 SEGMENTAL REVENUE MIX, 2020 (%) 128